<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >Deep Vein&nbsp;Thrombosis (DVT) is a common disease although often asymptomatic. The deep veins of the lower limbs are affected most commonly,&nbsp;but thrombosis may affect other sites, including the upper limbs,&nbsp;intracranial&nbsp;and&nbsp;splanchnic&nbsp;veins. Complications&nbsp;include&nbsp;pulmonary thromboembolism,&nbsp;which&nbsp;can&nbsp;be&nbsp;life-threatening.&nbsp;It&nbsp;is&nbsp;therefore essential to have a reliable method for establishing the DVT risk of patients and to take&nbsp;active&nbsp;steps&nbsp;to&nbsp;provide&nbsp;prophylactic&nbsp;treatment&nbsp;as&nbsp;necessary.&nbsp;Common risk factors for DVT include obesity,&nbsp;smoking, prolonged immobility (e.g. bed rest, long haul flights), major surgery e.g. orthopaedic, abdominal and pelvic surgery,&nbsp;pregnancy and the puerperium, after caesarean section, malignancies, inherited blood disorders, oestrogen therapy and medical conditions, e.g. congestive cardiac failure, myocardial infarction, nephrotic syndrome, stroke, systemic lupus&nbsp;erythematosus.</span></p><p style="text-align:justify;"><span >In cases of confirmed DVT,&nbsp;treatment with anticoagulants must not be&nbsp;delayed&nbsp;unnecessarily&nbsp;unless&nbsp;there&nbsp;are&nbsp;significant&nbsp;contraindications&nbsp;to their use such as recent intracerebral bleed, severe liver disease, active peptic ulcer,&nbsp;bleeding disorders, and severe&nbsp;hypertension.</span></p><h3>CAUSES</h3><p>•&nbsp; Stagnation of blood in the&nbsp;vein</p><p>•&nbsp; Increased viscosity of&nbsp;blood</p><p>•&nbsp; Inflammation of the blood vessel causing&nbsp;damage</p><p><strong>SYMPTOMS</strong></p><p>•&nbsp; Swelling&nbsp;or&nbsp;firmness&nbsp;of&nbsp;affected&nbsp;limb&nbsp;(usually&nbsp;unilateral)</p><p>•&nbsp; Pain in the affected&nbsp;limb</p><p>•&nbsp; Mild&nbsp;fever</p><h3>SIGNS</h3><p>•&nbsp; Swelling of affected&nbsp;limb</p><p>•&nbsp; Differential&nbsp;warmth</p><p>•&nbsp; Tenderness</p><p>•&nbsp; Redness</p><p>•&nbsp; Pitting&nbsp;oedema</p><p>•&nbsp; Prominent superficial&nbsp;veins</p><p>&nbsp;</p><h3>INVESTIGATIONS</h3><p>•&nbsp; D-Dimer&nbsp;test</p><p>•&nbsp; Doppler&nbsp;ultrasound</p><p>•&nbsp; Thrombophilia&nbsp;screen&nbsp;e.g.protein&nbsp;C,&nbsp;proteinS&nbsp;levels&nbsp;(in&nbsp;patients&nbsp;with recurrent&nbsp;DVT)</p><p>•&nbsp; FBC</p><p>&nbsp;</p><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To&nbsp;prevent clot propagation and pulmonary&nbsp;embolism</li><li>To&nbsp;prevent&nbsp;recurrence</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Avoidance of prolonged recumbency and&nbsp;dehydration</li><li>Avoidance of excess amounts of coffee, tea and alcohol, especially on long journeys</li><li>Increase water intake&nbsp;during long journeys or periods of&nbsp;immobility</li><li style="text-align:justify;">Regular exercise during long journeys e.g. stopping on road journeys to take a walk or moving about on a plane during long flights and leg flexing exercises while&nbsp;seated</li><li style="text-align:justify;">Avoid crossing legs for long periods on long&nbsp;journeys</li><li style="text-align:justify;">Use of elastic compression stockings</li></ul><h3 style="text-align:justify;">Pharmacological treatment</h3><p style="text-align:justify;"><span ><strong>A. DVT Prophylaxis</strong></span></p><p><span ><strong>1<sup>st</sup> Line treatment Evidence Rating: [A]</strong></span></p><ul><li>Heparin,&nbsp;SC,</li></ul><p><strong><u>Adults</u></strong></p><p>5,000 units 8-12 hourly</p><p><strong><u>Children</u></strong></p><p>1 month-18 years; 250 units/kg 12 hourly</p><p><span ><strong>2<sup>nd</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Enoxaparin,&nbsp;SC,</li></ul><p><strong><u>Adults</u></strong></p><p>40 mg daily</p><p><strong><u>Children</u></strong></p><p>2&nbsp;months-18&nbsp;years; 500 microgram /kg 12 hourly (max 40&nbsp;mg)</p><p>1-2&nbsp;months; 750 microgram /kg 12&nbsp;hourly</p><h3><span >B. &nbsp;DVT&nbsp;Treatment</span></h3><p><span ><strong>1<sup>st</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Heparin,&nbsp;SC,</li></ul><p><strong><u>Children</u></strong></p><p>1 month-18 years; 250 units /kg 12 hourly</p><h3>Or</h3><ul><li>Heparin, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>80 units/kg stat. continue with 18 units/kg / hour</p><h3>Or</h3><p>250 units/kg, SC, continue with 250 units /kg 12 hourly</p><p><strong><u>Children</u></strong></p><p><strong>1-18 years; </strong>75 units/kg stat. continue with 20 units/kg/hour</p><p><strong>1 month-1 year; </strong>75 units/kg stat. continue with 25 units/kg/ hour</p><p><strong><u>Neonates</u> (term baby); </strong>75 units/kg stat. continue with 25 units/kg/ hour</p><p><strong><u>Neonates</u> (&lt; 35 weeks); </strong>50 Units /kg stat. continue with 25 units/ kg/hour</p><p><span ><strong>2<sup>nd</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Enoxaparin,&nbsp;SC,</li></ul><p><strong><u>Adults</u></strong></p><p>1.5 mg/kg (150 units/kg) daily</p><p><strong><u>Children</u></strong></p><p>2 months-18&nbsp;years;&nbsp;1 mg/kg 12&nbsp;hourly</p><p>1-2&nbsp;months;1.5 mg/kg 12&nbsp;hourly</p><p><u>Neonates</u>; &nbsp;1.5-2 mg/kg 12&nbsp;hourly</p><h3>Or</h3><ul><li>Dalteparin,&nbsp;SC,</li></ul><p><strong><u>Adults</u></strong></p><p>200 mg/kg (max. of 18,000 units) daily</p><p><strong><u>Children</u></strong></p><p>12-18&nbsp;years;&nbsp;200 units/kg once daily (max 18,000 units daily)</p><p>1&nbsp;month-12&nbsp;years;100 units/kg 12&nbsp;hourly</p><p><u>Neonates</u>; 100 units/kg 12&nbsp;hourly</p><p><span ><strong>And</strong></span></p><p>•&nbsp; Warfarin, oral,<u>&nbsp;</u></p><p><strong><u>Adults</u>&nbsp;</strong></p><p>Loading&nbsp;Dose</p><p>&nbsp;</p><h3>REFERRAL CRITERIA</h3><p><span >Refer to physician specialist for management and monitoring.</span></p>
</body>
</html>
